Gartner (IT) Q1 2026 Earnings Call Transcript

Gartner reported Q1 revenue of $1.5 billion, up 2% year over year, with EBITDA rising 6% to $395 million, adjusted EPS up 11% to $3.32, and free cash flow up 29% to $371 million. Management raised 2026 guidance for revenue to at least $6.405 billion, EBITDA to at least $1.545 billion, adjusted EPS to at least $13.25, and free cash flow to at least $1.16 billion, while buying back $535 million of stock and expanding the repurchase authorization to about $1.2 billion. Contract value grew 1% overall and 3.5% ex-U.S. federal, but March decision-making slowed due to geopolitics and the U.S. federal business remains a headwind.

Analysis

The key signal is not the beat itself; it’s that Gartner is exiting a demand shock with operating leverage intact and a much cleaner capital-return setup. The company is now compounding two accelerants at once: a lagged recovery in contract conversions/new business and a lower share base, which means even modest top-line improvement can translate into outsized EPS revisions over the next 2-3 quarters. That makes the stock more sensitive to incremental buying momentum than to the headline growth rate.

The second-order winner is less obvious: this is a direct beneficiary of prolonged macro uncertainty. When decision cycles lengthen, Gartner’s value proposition shifts from “nice-to-have research” to “risk mitigation / decision insurance,” which tends to preserve wallet share even when client counts wobble. That dynamic likely supports resilience in enterprise budgets across IT, supply chain, and finance, and should also help vendors and conference spend normalize before consulting fully recovers.

The biggest near-term risk is a false dawn in the March-to-April improvement narrative. If April closures were mostly pull-forward rather than genuine reacceleration, the market could overestimate the slope of the recovery and compress the multiple back to a low-teens grower. The more durable tailwind is the federal lapping in Q2 combined with ongoing buybacks; if either stalls, the 12% EPS CAGR story becomes increasingly reliant on margin expansion, which is harder to sustain without reaccelerating CV.

Contrarian view: the market may still be underpricing the optionality from capital deployment. With substantial free cash flow and a reduced share count, Gartner does not need a heroic revenue inflection to deliver attractive per-share compounding. The stock likely works best as a boring-but-compounding quality name, not as a pure growth multiple re-rating story.

Key Decisions for Investors

• Go long IT on any post-earnings pullback in the next 1-2 weeks; thesis is EPS/revision support from buybacks plus a Q2 federal lap, with 12-18 month upside if CV reacceleration proves real.
• Pair trade: long IT / short a higher-multiple enterprise software name with weaker cash generation over the next 3-6 months; Gartner has better near-term per-share compounding and less dependence on AI monetization proof.
• Sell downside protection by writing IT puts 1-2 quarters out if implied vol stays elevated; the cash-flow floor and repurchase bid should cap left-tail risk absent a renewed macro shock.
• If looking for a tactical catalyst, buy IT ahead of Q2 results and use a 10-15% stop; the stock should react positively if management confirms that April close rates are normalizing.
• Avoid chasing if the stock gaps sharply higher on the print; the cleanest entry is on a de-risking move because the bull case is mostly operating leverage, not multiple expansion.